Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Current Value
$42.821 Year Return
Current Value
$42.821 Year Return
Market Cap
$5.16B
P/E Ratio
-14.92
1Y Stock Return
638.05%
1Y Revenue Growth
-0.19%
Dividend Yield
0.00%
Price to Book
3.4
Yahoo
NVAX and RNA are in the spotlight following Q3 results and study data, respectively.
Yahoo
Avidity Biosciences expands its pipeline to include two new drugs targeting rare genetic cardiomyopathies.
Yahoo
Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space.
Finnhub
SAN DIEGO - Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced it has expanded...
Yahoo
Avidity Biosciences ( NASDAQ:RNA ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.34m (down 17% from 3Q...
Yahoo
Avidity Biosciences (RNA) delivered earnings and revenue surprises of 17.72% and 67.05%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MITK | -0.01% | $401.51M | -22.13% | 0.00% |
PRPO | 0.02% | $9.10M | -13.65% | 0.00% |
UTI | -0.07% | $1.07B | +73.54% | 0.00% |
AIFU | -0.08% | $67.49M | -83.02% | 0.00% |
OXBR | 0.11% | $19.05M | +178.18% | 0.00% |
COKE | 0.13% | $10.72B | +73.12% | 0.33% |
ARLP | -0.14% | $3.54B | +26.77% | 10.11% |
SSSS | 0.15% | - | - | 0.00% |
ZCMD | -0.17% | $2.80M | -88.67% | 0.00% |
TH | 0.19% | $839.02M | -24.49% | 0.00% |
GSBD | 0.20% | $1.53B | - | 13.99% |
FATBB | 0.21% | $81.94M | -12.91% | 11.69% |
MLCO | -0.23% | $2.51B | -16.48% | 0.00% |
HIHO | -0.25% | $8.63M | 0.00% | 6.12% |
ALTO | -0.27% | $106.54M | -39.83% | 0.00% |
PHI | -0.27% | $4.83B | -1.80% | 7.58% |
SYRS | 0.28% | $7.43M | -90.46% | 0.00% |
NTZ | -0.28% | $47.64M | -30.94% | 0.00% |
RWAY | 0.30% | $394.72M | -17.18% | 15.47% |
MX | 0.34% | $135.79M | -45.52% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DYN | 45.48% | $3.02B | +182.40% | 0.00% |
ALEC | 39.91% | $377.04M | -19.46% | 0.00% |
MFA | 39.43% | $1.13B | +5.15% | 12.73% |
ACLX | 39.36% | $4.74B | +69.19% | 0.00% |
SWTX | 38.91% | $2.82B | +79.34% | 0.00% |
SLG | 38.11% | $5.09B | +133.31% | 3.89% |
RXRX | 37.52% | $1.80B | -4.13% | 0.00% |
SNDX | 37.28% | $1.35B | +2.87% | 0.00% |
NTLA | 37.06% | $1.44B | -50.35% | 0.00% |
RVMD | 35.63% | $9.50B | +171.62% | 0.00% |
ARWR | 35.56% | $2.31B | -34.44% | 0.00% |
HIW | 35.27% | $3.34B | +74.29% | 6.42% |
NTRA | 35.13% | $21.40B | +200.46% | 0.00% |
DX | 35.05% | $991.29M | +9.75% | 12.54% |
HHH | 34.92% | $3.98B | +14.89% | 0.00% |
DAWN | 34.67% | $1.36B | +13.42% | 0.00% |
ORA | 34.64% | $4.80B | +20.68% | 0.61% |
AI | 34.53% | $4.19B | +15.61% | 0.00% |
PLRX | 34.41% | $778.32M | -9.55% | 0.00% |
ALDX | 34.36% | $294.18M | +102.46% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -20.40% | $21.46B | +15.84% | 1.11% |
COR | -18.54% | $47.48B | +21.20% | 0.86% |
MCK | -12.67% | $78.15B | +35.51% | 0.42% |
PGR | -12.54% | $149.10B | +57.29% | 0.45% |
LMT | -11.43% | $126.40B | +18.99% | 2.36% |
ACGL | -10.07% | $36.00B | +16.84% | 0.00% |
GIS | -9.86% | $34.85B | -2.91% | 3.78% |
RNR | -9.76% | $13.74B | +23.09% | 0.58% |
AVAL | -9.37% | $791.37M | -4.11% | 7.14% |
MOH | -8.84% | $16.16B | -21.56% | 0.00% |
CYCN | -8.70% | $4.77M | -16.19% | 0.00% |
CI | -7.85% | $89.70B | +12.57% | 1.68% |
ALL | -7.81% | $52.06B | +45.67% | 1.85% |
XEL | -7.64% | $41.42B | +15.91% | 3.12% |
TPST | -7.64% | $37.75M | -77.59% | 0.00% |
UUU | -7.50% | $4.97M | -41.89% | 0.00% |
WRB | -7.43% | $22.94B | +29.98% | 0.69% |
NAPA | -7.41% | $1.63B | +9.61% | 0.00% |
HUSA | -7.37% | $16.69M | -11.56% | 0.00% |
WM | -6.97% | $87.92B | +27.58% | 1.34% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -35.37% | $388.04M | 1.43% |
VIXY | -22.83% | $195.31M | 0.85% |
CTA | -14.89% | $350.27M | 0.78% |
KRBN | -14.66% | $242.47M | 0.85% |
USDU | -13.17% | $201.97M | 0.5% |
UUP | -12.64% | $309.25M | 0.77% |
CORN | -10.69% | $61.12M | 0.2% |
AGZD | -9.09% | $142.76M | 0.23% |
EQLS | -8.63% | $76.08M | 1% |
HDRO | -8.42% | $164.26M | 0.3% |
WEAT | -8.28% | $120.27M | 0.28% |
KMLM | -7.62% | $353.87M | 0.9% |
KCCA | -6.97% | $220.51M | 0.87% |
TAIL | -6.87% | $67.98M | 0.59% |
SGOV | -5.60% | $27.53B | 0.09% |
BOXX | -3.90% | $4.43B | 0.1949% |
MINT | -3.28% | $11.62B | 0.35% |
IBDP | -3.02% | $2.11B | 0.1% |
SOYB | -2.47% | $27.32M | 0.22% |
CANE | -2.39% | $17.72M | 0.29% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 49.74% | $70.59M | 0.5% |
PTH | 48.65% | $143.31M | 0.6% |
XBI | 46.78% | $6.58B | 0.35% |
IBB | 42.04% | $6.66B | 0.45% |
IWC | 40.19% | $933.99M | 0.6% |
RSPA | 39.63% | $273.87M | 0% |
IWO | 39.52% | $12.56B | 0.24% |
PBE | 39.44% | $258.53M | 0.58% |
NUSC | 39.28% | $1.27B | 0.31% |
ISCG | 38.99% | $640.00M | 0.06% |
PBW | 38.68% | $301.18M | 0.65% |
MORT | 38.53% | $293.96M | 0.43% |
VBK | 38.38% | $19.31B | 0.07% |
VTWO | 38.38% | $12.38B | 0.1% |
TMSL | 38.30% | $288.12M | 0.55% |
QQQJ | 38.24% | $698.04M | 0.15% |
IWM | 38.17% | $75.73B | 0.19% |
VXF | 38.11% | $21.54B | 0.06% |
KOMP | 38.02% | $2.09B | 0.2% |
QQA | 37.96% | $135.01M | 0% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | 0.03% | $40.60M | 0.65% |
DBA | 0.08% | $755.88M | 0.93% |
CCOR | 0.15% | $109.04M | 1.18% |
CSHI | 0.21% | $482.85M | 0.38% |
GBIL | 0.81% | $5.60B | 0.12% |
FMF | 1.02% | $244.61M | 0.95% |
BSCO | 1.41% | $2.35B | 0.1% |
TBIL | -1.42% | $4.38B | 0.15% |
XBIL | 1.56% | $637.70M | 0.15% |
BILZ | 1.62% | $563.02M | 0.14% |
FLRN | -1.81% | $2.33B | 0.15% |
CANE | -2.39% | $17.72M | 0.29% |
SOYB | -2.47% | $27.32M | 0.22% |
JBBB | 2.84% | $1.26B | 0.49% |
IBDP | -3.02% | $2.11B | 0.1% |
DBO | 3.19% | $217.57M | 0.77% |
MINT | -3.28% | $11.62B | 0.35% |
IYK | 3.88% | $1.30B | 0.4% |
BOXX | -3.90% | $4.43B | 0.1949% |
XHLF | 4.46% | $874.27M | 0.03% |